Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

Several organizations have developed frameworks to systematically assess the value of new drugs. These organizations include the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), the Institute for Clinical and Economic Review (ICER), and the National Com...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Value in health Ročník 20; číslo 2; s. 200 - 205
Hlavní autori:	Bentley, Tanya G.K., Cohen, Joshua T., Elkin, Elena B., Huynh, Julie, Mukherjea, Arnab, Neville, Thanh H., Mei, Matthew, Copher, Ronda, Knoth, Russell, Popescu, Ioana, Lee, Jackie, Zambrano, Jenelle M., Broder, Michael S.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 01.02.2017 Elsevier Science Ltd
Predmet:	Antineoplastic Agents - standards Cancer Confidence intervals Convergent validity Decision making Decision Support Techniques Drugs Evaluation Feedback Health care inter-rater reliability Internal Medicine Lung cancer Medical decision making Medical Oncology Oncology Pilot Projects Reliability Reproducibility of Results Sensitivity analysis Validity Value value frameworks Value-Based Purchasing convergent validity value frameworks oncology inter-rater reliability
ISSN:	1098-3015, 1524-4733, 1524-4733
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!